日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

接受达拉非尼单药治疗的BRAF V600突变转移性黑色素瘤患者的长期疗效:来自2期和3期临床试验的分析

Hauschild, Axel; Ascierto, Paolo A; Schadendorf, Dirk; Grob, Jean Jacques; Ribas, Antoni; Kiecker, Felix; Dutriaux, Caroline; Demidov, Lev V; Lebbé, Céleste; Rutkowski, Piotr; Blank, Christian U; Gutzmer, Ralf; Millward, Michael; Kefford, Richard; Haas, Tomas; D'Amelio, Anthony Jr; Gasal, Eduard; Mookerjee, Bijoyesh; Chapman, Paul B

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

在BRAF突变型黑色素瘤中,BRAF和MEK抑制剂联合PD-1阻断免疫疗法

Ribas, Antoni; Lawrence, Donald; Atkinson, Victoria; Agarwal, Sachin; Miller, Wilson H Jr; Carlino, Matteo S; Fisher, Rosalie; Long, Georgina V; Hodi, F Stephen; Tsoi, Jennifer; Grasso, Catherine S; Mookerjee, Bijoyesh; Zhao, Qing; Ghori, Razi; Moreno, Blanca Homet; Ibrahim, Nageatte; Hamid, Omid

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

接受达拉非尼联合曲美替尼治疗的BRAF V600突变转移性黑色素瘤患者的长期疗效

Long, Georgina V; Eroglu, Zeynep; Infante, Jeffrey; Patel, Sapna; Daud, Adil; Johnson, Douglas B; Gonzalez, Rene; Kefford, Richard; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Sharfman, William; McWilliams, Robert; Sznol, Mario; Redhu, Suman; Gasal, Eduard; Mookerjee, Bijoyesh; Weber, Jeffrey; Flaherty, Keith T

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

达拉非尼和曲美替尼治疗局部晚期或转移性BRAF V600突变型间变性甲状腺癌患者

Subbiah, Vivek; Kreitman, Robert J; Wainberg, Zev A; Cho, Jae Yong; Schellens, Jan H M; Soria, Jean Charles; Wen, Patrick Y; Zielinski, Christoph; Cabanillas, Maria E; Urbanowitz, Gladys; Mookerjee, Bijoyesh; Wang, Dazhe; Rangwala, Fatima; Keam, Bhumsuk

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF(V600E)-Mutant Colorectal Cancer

BRAF、EGFR 和 MEK 联合抑制治疗 BRAF(V600E) 突变型结直肠癌患者

Corcoran, Ryan B; André, Thierry; Atreya, Chloe E; Schellens, Jan H M; Yoshino, Takayuki; Bendell, Johanna C; Hollebecque, Antoine; McRee, Autumn J; Siena, Salvatore; Middleton, Gary; Muro, Kei; Gordon, Michael S; Tabernero, Josep; Yaeger, Rona; O'Dwyer, Peter J; Humblet, Yves; De Vos, Filip; Jung, A Scott; Brase, Jan C; Jaeger, Savina; Bettinger, Severine; Mookerjee, Bijoyesh; Rangwala, Fatima; Van Cutsem, Eric

Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

达拉非尼联合曲美替尼治疗BRAF(V600)突变型黑色素瘤脑转移患者(COMBI-MB):一项多中心、多队列、开放标签的II期试验

Davies, Michael A; Saiag, Philippe; Robert, Caroline; Grob, Jean-Jacques; Flaherty, Keith T; Arance, Ana; Chiarion-Sileni, Vanna; Thomas, Luc; Lesimple, Thierry; Mortier, Laurent; Moschos, Stergios J; Hogg, David; Márquez-Rodas, Iván; Del Vecchio, Michele; Lebbé, Céleste; Meyer, Nicolas; Zhang, Ying; Huang, Yingjie; Mookerjee, Bijoyesh; Long, Georgina V